Delivery Order SPE2DB20D1109-SPE2DB23FN19E
Award Date 12/16/22
Potential Completion Date 12/19/22
Potential Value $2.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses, to the Defense Logistics Agency (DLA). The $10,397.54 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with no set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,192.67 for 4,559,700,837 units of NARCAN 4 MG NASAL SPRAY 2S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of January 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,657.60 firm fixed-price delivery order is for the procurement of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used for opioid overdose reversal. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $1,203.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,328.22 delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose treatment medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical....
- This federal contract award, valued at $2,381.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for opioid overdose reversal. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a subsidiary of Cencora, Inc., is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The $4,593.74 firm-fixed-price delivery order has a completion date of January 5, 2023. This contract is not designated as a set-aside and was awarded through full and open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical emergency medication used to treat opioid overdoses, to the Defense Logistics Agency (DLA). The contract, valued at $2,271.68, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 16, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award, valued at $1,561.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose, to the Defense Logistics Agency (DLA). The $7,940.14 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 10, 2023, with a completion date of May 11, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) valued at up to...